Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCTL | Q9NXS2 | 6/20 | 0.47 |
| ▸ | QPCT | Q16769 | 5/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | GUSB | P08236 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25394737 | 0.87 | KDM4E (0.44) | QPCTLQPCTSNCAKDM4EALDH1A1 | |
| SCHEMBL30579919 | 0.87 | KDM4E (0.44) | QPCTLQPCTSNCAKDM4EALDH1A1 | |
| SCHEMBL25397902 | 0.83 | QPCTL (0.47) | QPCTLQPCTSNCAKDM4ECYP17A1 | |
| SCHEMBL31408961 | 0.83 | QPCTL (0.47) | QPCTLQPCTSNCAKDM4ECYP17A1 | |
| SCHEMBL25397560 | 0.83 | KIF11 (0.43) | QPCTCYP11B1CYP11B2 | |
| SCHEMBL25399572 | 0.83 | HDAC6 (0.34) | QPCTLQPCTKDM4EHDAC6IL4I1 | |
| SCHEMBL25416550 | 0.81 | HDAC1 (0.40) | QPCTLQPCTKDM4EALDH1A1MAPT | |
| SCHEMBL2537238 | 0.79 | MGAM (0.56) | KDM4EALDH1A1HDAC6NOTUMMGAM | |
| SCHEMBL27163421 | 0.79 | KDM4E (0.59) | QPCTLKDM4ENOTUMGAAHSD17B1 | |
| SCHEMBL31385361 | 0.77 | CA1 (0.45) | QPCTLQPCTSNCAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197363-A1 | THIADIAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, INCLUDING SAME | CUREVERSE INCORPORATED (KR) | 2025-06-19 | — | — | US | disclosed |
| EP-4495106-A1 | THIADIAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, INCLUDING SAME | Daegu-Gyeongbuk Medical Innovation Foundation (KR) | 2025-01-22 | — | — | EP | disclosed |
| CN-119212981-A | Thiadiazole compound and pharmaceutical composition for preventing or treating inflammatory diseases comprising the same | 财团法人 大邱庆北尖端医疗产业振兴财团 | 2024-12-27 | — | — | CN | disclosed |
| WO-2023177146-A1 | THIADIAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, INCLUDING SAME | 재단법인 대구경북첨단의료산업진흥재단 | 2023-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197363-A1 | THIADIAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, INCLUDING SAME | PPARD, PPARG, PPARA | QPCTL 2697/4885QPCT 2400/4885SNCA 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.